Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Beauvais

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The European Respiratory Journal|March 1, 1990
Opportunistic agents in bronchoalveolar lavage in 99 HIV seropositive patientsS Durand-Amat, G Zalcman, M C Mazeron, et al.
The Journal of Infectious Diseases|January 1, 1993
Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic featuresJ M Molina, C Sarfati, B Beauvais, et al.
Lancet (London, England)|July 27, 1985
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvementM Lariviere, P Vingtain, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. II. Evaluation in the light of mass campaigns on the effect of yearly or half-yearly administration of single oral doses of 100, 150 or 200 mcg/kg]M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]M Larivière, B Beauvais, M Aziz, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The European Respiratory Journal|March 1, 1990
Opportunistic agents in bronchoalveolar lavage in 99 HIV seropositive patientsS Durand-Amat, G Zalcman, M C Mazeron, et al.
The Journal of Infectious Diseases|January 1, 1993
Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic featuresJ M Molina, C Sarfati, B Beauvais, et al.
Lancet (London, England)|July 27, 1985
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvementM Lariviere, P Vingtain, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. II. Evaluation in the light of mass campaigns on the effect of yearly or half-yearly administration of single oral doses of 100, 150 or 200 mcg/kg]M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]M Larivière, B Beauvais, M Aziz, et al.
Pageof 4